ChiCTR2100049114
Untitled Trial
The safety, immunogenicity of inactivated COVID 19 vaccine in adult rheumatoid patients: a prospective cohort study
Shenzhen Futian Hospital for Rheumatic Diseases·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Shenzhen Futian Hospital for Rheumatic Diseases
- Funder
- Shenzhen city three project
- Location
- China
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- Jul 18, 2022
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100049114
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100049114 through Pure Global AI's free database. This phase not specified trial is sponsored by Shenzhen Futian Hospital for Rheumatic Diseases and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.